Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion type Assertion NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_head.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion evidence source_evidence_literature NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion SIO_000772 21147110 NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion wasDerivedFrom befree-20140225 NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion wasGeneratedBy ECO_0000203 NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.